• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗管理与结肠切除术率的变化:一项基于人群的队列研究,关于瑞典厄勒布鲁1963 - 2010年溃疡性结肠炎的流行病学与自然史

Changes in medical management and colectomy rates: a population-based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963-2010.

作者信息

Eriksson C, Cao Y, Rundquist S, Zhulina Y, Henriksson I, Montgomery S, Halfvarson J

机构信息

Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.

出版信息

Aliment Pharmacol Ther. 2017 Oct;46(8):748-757. doi: 10.1111/apt.14268. Epub 2017 Aug 17.

DOI:10.1111/apt.14268
PMID:28833287
Abstract

BACKGROUND

Whether the epidemiology of ulcerative colitis (UC) has changed during recent decades is partly unknown.

AIM

To depict temporal trends in the epidemiology and medical treatment of UC as well as the long-term risk of progression in disease extent and colectomy, during 1963-2010.

METHODS

Patients were identified by evaluation of all medical records in the archive of the Colitis Clinic, Örebro University Hospital. Comparisons were made between three time periods, 1963-1975, 1976-1990 and 1991-2005.

RESULTS

The annual age-standardised incidence increased from 3.5 to 18.5 per 100 000 during the study period (P < .01). Correspondingly, the prevalence increased from 44 to 474 per 100 000 between 1965 and 2010. A higher proportion of males than females had extensive colitis at diagnosis (odds ratio: 1.55; 95% CI 1.17-2.05; P < .01). The risk for progression in disease extent was 34.5% and 18.5% at 10 years, for patients with proctitis and left-sided colitis, respectively (P < .01). The use of 5-aminosalicylates, within 10 years, rise from 79% to 92% between 1963-1975 and 1976-1990 (P < .01). Thiopurine use increased from 7% in 1976-1990 to 34% during 1991-2005 (P < .01). The colectomy rate at 10 years was 13.5% (95% CI 11.1%-15.8%), and the risk was lower among patients diagnosed in 1991-2005 compared to 1963-1975 (adjusted hazard ratio: 0.61; 95% CI 0.39-0.94; P = .02).

CONCLUSION

The incidence and prevalence of UC increased over time, and the observed prevalence in 2010 is among the highest reported. In parallel, a decrease in colectomy rates was observed during the most recent decades, potentially reflecting improved medical treatment.

摘要

背景

溃疡性结肠炎(UC)的流行病学在近几十年是否发生变化尚不完全清楚。

目的

描述1963年至2010年期间UC的流行病学、医学治疗的时间趋势,以及疾病范围进展和结肠切除术的长期风险。

方法

通过评估厄勒布鲁大学医院结肠炎诊所档案中的所有病历确定患者。对1963 - 1975年、1976 - 1990年和1991 - 2005年三个时间段进行比较。

结果

在研究期间,年龄标准化年发病率从每10万人3.5例增加到18.5例(P <.01)。相应地,1965年至2010年间,患病率从每10万人44例增加到474例。诊断时患有广泛性结肠炎的男性比例高于女性(优势比:1.55;95%可信区间1.17 - 2.05;P <.01)。直肠炎和左侧结肠炎患者在10年时疾病范围进展的风险分别为34.5%和18.5%(P <.01)。10年内,5 - 氨基水杨酸酯的使用在1963 - 1975年至1976 - 1990年间从79%上升到92%(P <.01)。硫嘌呤的使用从1976 - 1990年的7%增加到1991 - 2005年的34%(P <.01)。10年时结肠切除率为13.5%(95%可信区间11.1% - 15.8%),与1963 - 1975年诊断的患者相比,1991 - 2005年诊断的患者风险较低(调整后风险比:0.61;95%可信区间0.39 - 0.94;P =.02)。

结论

UC的发病率和患病率随时间增加,2010年观察到的患病率是报告的最高患病率之一。同时,在最近几十年观察到结肠切除率下降,这可能反映了医学治疗的改善。

相似文献

1
Changes in medical management and colectomy rates: a population-based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963-2010.医疗管理与结肠切除术率的变化:一项基于人群的队列研究,关于瑞典厄勒布鲁1963 - 2010年溃疡性结肠炎的流行病学与自然史
Aliment Pharmacol Ther. 2017 Oct;46(8):748-757. doi: 10.1111/apt.14268. Epub 2017 Aug 17.
2
Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005-2009.溃疡性结肠炎诊断五年后的低位结肠切除术率。瑞典一项基于人群的前瞻性队列研究(ICURE)在2005年至2009年期间诊断的结果。
Scand J Gastroenterol. 2016 Nov;51(11):1339-44. doi: 10.1080/00365521.2016.1200141. Epub 2016 Jun 29.
3
Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years.在一个未经挑选的欧洲队列中,溃疡性结肠炎患者接受低位结肠切除术的比例随访了10年。
Gastroenterology. 2007 Feb;132(2):507-15. doi: 10.1053/j.gastro.2006.11.015. Epub 2006 Nov 15.
4
Long-term prognosis of ulcerative colitis and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea.韩国首尔松坡-江东地区基于人群队列的溃疡性结肠炎长期预后及其在1986年至2015年间的时间变化
Gut. 2020 Aug;69(8):1432-1440. doi: 10.1136/gutjnl-2019-319699. Epub 2019 Dec 10.
5
Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005-2009 - results from the IBD cohort of the Uppsala Region (ICURE).2005-2009 年瑞典乌普萨拉地区溃疡性结肠炎的发病和自然史——乌普萨拉地区炎症性肠病队列(ICURE)的结果。
J Crohns Colitis. 2013 Oct;7(9):e351-7. doi: 10.1016/j.crohns.2013.02.006. Epub 2013 Mar 9.
6
Epidemiology, Treatment Strategy, Natural Disease Course and Surgical Outcomes of Patients with Ulcerative Colitis in Western Hungary - A Population-based Study Between 2007 and 2018: Data from the Veszprem County Cohort.匈牙利西部溃疡性结肠炎患者的流行病学、治疗策略、自然病程及手术结果——基于2007年至2018年韦伦采县队列的人群研究
J Crohns Colitis. 2023 Apr 3;17(3):352-360. doi: 10.1093/ecco-jcc/jjac142.
7
Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.结肠切除术是溃疡性结肠炎患者发生静脉血栓栓塞的一个危险因素。
World J Gastroenterol. 2015 Jan 28;21(4):1251-60. doi: 10.3748/wjg.v21.i4.1251.
8
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).溃疡性结肠炎最初10年的临床病程:基于人群的发病队列研究结果(IBSEN研究)
Scand J Gastroenterol. 2009;44(4):431-40. doi: 10.1080/00365520802600961.
9
The natural history of pediatric ulcerative colitis: a population-based cohort study.儿童溃疡性结肠炎的自然病史:一项基于人群的队列研究。
Am J Gastroenterol. 2009 Aug;104(8):2080-8. doi: 10.1038/ajg.2009.177. Epub 2009 May 12.
10
Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study.溃疡性直肠炎是儿童发病 UC 的常见部位,并非小病:一项基于人群的研究。
Gut. 2017 Nov;66(11):1912-1917. doi: 10.1136/gutjnl-2016-311970. Epub 2016 Aug 3.

引用本文的文献

1
Healthcare resource utilization and production loss in vedolizumab-treated inflammatory bowel disease patients: results from the Swedish prospective multicentre SVEAH study.维多珠单抗治疗的炎症性肠病患者的医疗资源利用和生产损失:瑞典前瞻性多中心SVEAH研究的结果
Therap Adv Gastroenterol. 2025 Jul 17;18:17562848251352023. doi: 10.1177/17562848251352023. eCollection 2025.
2
A Longitudinal Post-authorization Safety Study of Golimumab in Treatment of Ulcerative Colitis: A Cohort Study in Denmark and Sweden, 2013-2021.戈利木单抗治疗溃疡性结肠炎的长期授权后安全性研究:2013 - 2021年丹麦和瑞典的队列研究
Drug Saf. 2025 May;48(5):541-558. doi: 10.1007/s40264-025-01519-8. Epub 2025 Feb 6.
3
Genetic Analysis of Biopsy Tissues from Colorectal Tumors in Patients with Ulcerative Colitis.
溃疡性结肠炎患者结直肠肿瘤活检组织的基因分析
Cancers (Basel). 2024 Sep 26;16(19):3271. doi: 10.3390/cancers16193271.
4
The Association of Race, Ethnicity, and Insurance Status With Outcomes in Hospitalized Patients With Ulcerative Colitis.种族、族裔和保险状况与溃疡性结肠炎住院患者预后的关联
Gastro Hep Adv. 2022 Jul 31;1(6):985-992. doi: 10.1016/j.gastha.2022.07.016. eCollection 2022.
5
Natural course of ulcerative colitis in China: Differences from the West?中国溃疡性结肠炎的自然病程:与西方的不同之处?
United European Gastroenterol J. 2024 Nov;12(9):1167-1178. doi: 10.1002/ueg2.12634. Epub 2024 Jul 19.
6
Changes in the clinical course and prognosis of ulcerative colitis in Chinese populations: a retrospective cohort study.中国人群溃疡性结肠炎临床病程及预后的变化:一项回顾性队列研究
Intest Res. 2024 Jul;22(3):357-368. doi: 10.5217/ir.2023.00106. Epub 2024 May 7.
7
Pouchitis: pathophysiology and management.袋炎:病理生理学与管理
Nat Rev Gastroenterol Hepatol. 2024 Jul;21(7):463-476. doi: 10.1038/s41575-024-00920-5. Epub 2024 Apr 25.
8
Can we change the natural course of inflammatory bowel disease?我们能否改变炎症性肠病的自然病程?
Therap Adv Gastroenterol. 2023 Apr 17;16:17562848231163118. doi: 10.1177/17562848231163118. eCollection 2023.
9
Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting.阿达木单抗修饰的纳米颗粒增强了上皮性结肠炎靶向治疗中的抗体稳定性和治疗效果。
Pharmaceutics. 2022 Feb 2;14(2):352. doi: 10.3390/pharmaceutics14020352.
10
Natural history of inflammatory bowel disease: a comparison between the East and the West.炎症性肠病的自然史:东西方比较
Intest Res. 2022 Oct;20(4):418-430. doi: 10.5217/ir.2021.00104. Epub 2021 Dec 2.